BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 33680972)

  • 1. CD96 Correlates With Immune Infiltration and Impacts Patient Prognosis: A Pan-Cancer Analysis.
    Ye W; Luo C; Liu F; Liu Z; Chen F
    Front Oncol; 2021; 11():634617. PubMed ID: 33680972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer Analysis.
    Ye W; Luo C; Li C; Liu Z; Liu F
    J Cancer; 2021; 12(21):6588-6599. PubMed ID: 34659549
    [No Abstract]   [Full Text] [Related]  

  • 3. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MARCO is a potential prognostic and immunotherapy biomarker.
    Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X
    Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune and Clinical Features of
    Zhang Q; Zhong H; Fan Y; Liu Q; Song J; Yao S; Cao F
    Front Bioeng Biotechnol; 2020; 8():592. PubMed ID: 32695752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
    Wang Y; Gong H; Cao Y
    Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction.
    Li H; Sun X; Zhao Y; Zhang C; Jiang K; Ren J; Xing L; He M
    BMC Cancer; 2023 Jun; 23(1):528. PubMed ID: 37296415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pan-Cancer Analysis of the Oncogenic Role of
    Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
    Front Genet; 2022; 13():906174. PubMed ID: 35910232
    [No Abstract]   [Full Text] [Related]  

  • 9. Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance.
    Ma J; Jin Y; Gong B; Li L; Zhao Q
    Discov Oncol; 2022 Mar; 13(1):17. PubMed ID: 35312867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value and immunological role of cathepsin S gene in pan‑cancer.
    Liang S; Dang B; Chen S; Mi H
    Oncol Lett; 2024 Jan; 27(1):41. PubMed ID: 38108072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
    Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
    Front Oncol; 2022; 12():927988. PubMed ID: 35756681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients.
    Huang B; Han W; Sheng ZF; Shen GL
    Cancer Cell Int; 2020; 20():195. PubMed ID: 32508531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Expression of the
    Hu J; Xu J; Feng X; Li Y; Hua F; Xu G
    Front Cell Dev Biol; 2021; 9():700661. PubMed ID: 34631699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 16. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
    Fan Y; Liang X; Yu D
    Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel IKZF3 transcriptomic signature correlates with positive outcomes of skin cutaneous melanoma: A pan-cancer analysis.
    Yang LK; Lin CX; Li SH; Liang JJ; Xiao LL; Xie GH; Liu HW; Liao X
    Front Genet; 2022; 13():1036402. PubMed ID: 36353107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of NLRP3 in the prognosis and immune infiltrates of skin cutaneous melanoma (SKCM).
    Wu S; Zang Q; Dai B
    Transl Cancer Res; 2021 Apr; 10(4):1692-1702. PubMed ID: 35116494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 20. FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma.
    Wu S; Liang Y; Zang Q; Xing Z; Yin P; Sun R; Dai B
    Appl Bionics Biomech; 2022; 2022():5160748. PubMed ID: 35607429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.